Outcomes of critically ill cancer patients with Acinetobacter baumannii infection

Table 1 Demographic and clinical characteristics of the study population

Characteristics	Values
No. of patients	23
Age (years), mean ± SD	44.09 ± 17.10
Gender (women), n (%)	11 (47.8)
Length of ICU stay (d), mean ± SD	21.9 ± 28.9
Length of hospital stay (d), mean ± SD	23.9 ± 12.3
Need for vasopressors, n (%)	23 (100)
Need for invasive mechanical ventilation, n (%)	23 (100)
Length of mechanical ventilation (d), mean ± SD	21.4 ± 11.8
In hospital ward time before ICU admission, n (%)	20 (86.9)
Length of stay in hospital wards before ICU admission (d), mean ± SD	8.8 ± 10.6
Use of antibiotics 30 days before ICU admission, n (%)	17 (73.9)
Infection site, n (%)
Respiratory	21 (91.3)
Blood culture	3 (13)
Surgical site	1 (4.3)
Pansensitive, n (%)	2 (8.7)
Pandrug-resistant, n (%)	5 (21.7)
Multidrug-resistant, n (%)	16 (69.6)
APACHE II score, mean ± SD	13.3 ± 5.8
SOFA score, mean ± SD	8.7 ± 2.4
Performance status 0-2, n (%)	22 (95.7)
ICU mortality, n (%)	6 (26.1)
Hospital mortality, n (%)	10 (43.5)

ICU: Intensive care unit; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; IQR: Interquartile range; PEEP: Positive end expiratory pressure.